|
|
|
|
||
Strong Buy
Re: New Yorker 22Dec2014 Article "Can AiDS be Cured?"Like ISIS for example. Many excellent partnerships and licenses. What are they up to now? Some 32 in the clinic in the past 5 years. with more than 65 in the preclinical pipeline from what the CEO has said. No shrinking violate there:) I think they deals with almost every major BP. If the IVPR platform is so easy, once it starts, where are all of those other people that seem to all be looking for drugs to bring to market. With lots of cash in most cases. It is all in Edwards hands, deliver, not deliver. "B" |
return to message board, top of board |